Pfizer Drops by Most Since July as Sales of Key Drugs Disappoint

(Bloomberg) -- Pfizer Inc. says its future looks good, but investors are registering their concern about the present.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.